137 related articles for article (PubMed ID: 1272148)
1. Antibody response to one and two doses of influenza virus subunit vaccine.
Feery BJ; Cheyne IM; Hampson AW; Atkinson MI
Med J Aust; 1976 Feb; 1(7):186, 188-9. PubMed ID: 1272148
[TBL] [Abstract][Full Text] [Related]
2. Influenza vaccine immunogenicity in 6- to 23-month-old children: are identical antigens necessary for priming?
Walter EB; Neuzil KM; Zhu Y; Fairchok MP; Gagliano ME; Monto AS; Englund JA
Pediatrics; 2006 Sep; 118(3):e570-8. PubMed ID: 16950948
[TBL] [Abstract][Full Text] [Related]
3. A study of acute respiratory disease in the community of Port Chalmers. III. Efficacy of influenza virus subunit vaccines in 1973, 1974 and 1975.
Jennings LC; MacDiarmid RD; Miles JA
N Z Med J; 1980 Sep; 92(668):230-3. PubMed ID: 6935541
[TBL] [Abstract][Full Text] [Related]
4. Is there a benefit from an early booster vaccination in the control of equine influenza?
Heldens JG; van Loon AA; van de Zande S
Vet J; 2007 Nov; 174(3):592-8. PubMed ID: 17560150
[TBL] [Abstract][Full Text] [Related]
5. Effects of repeated annual influenza vaccination on antibody responses against unchanged vaccine antigens in elderly frail institutionalized volunteers.
Iorio AM; Camilloni B; Basileo M; Neri M; Lepri E; Spighi M
Gerontology; 2007; 53(6):411-8. PubMed ID: 17975317
[TBL] [Abstract][Full Text] [Related]
6. Impaired serum antibody response to inactivated influenza A and B vaccine in cancer patients.
Stiver HG; Weinerman BH
Can Med Assoc J; 1978 Oct; 119(7):733,-5, 738. PubMed ID: 709474
[TBL] [Abstract][Full Text] [Related]
7. Antibody response to a two-dose regimen of influenza vaccine in allogeneic T cell-depleted and autologous BMT recipients.
Engelhard D; Nagler A; Hardan I; Morag A; Aker M; Baciu H; Strauss N; Parag G; Naparstek E; Ravid Z
Bone Marrow Transplant; 1993 Jan; 11(1):1-5. PubMed ID: 8431706
[TBL] [Abstract][Full Text] [Related]
8. Immunogenicity and reactogenicity of 1 versus 2 doses of trivalent inactivated influenza vaccine in vaccine-naive 5-8-year-old children.
Neuzil KM; Jackson LA; Nelson J; Klimov A; Cox N; Bridges CB; Dunn J; DeStefano F; Shay D
J Infect Dis; 2006 Oct; 194(8):1032-9. PubMed ID: 16991077
[TBL] [Abstract][Full Text] [Related]
9. Immune responses of healthy subjects to a single dose of intramuscular inactivated influenza A/Vietnam/1203/2004 (H5N1) vaccine after priming with an antigenic variant.
Goji NA; Nolan C; Hill H; Wolff M; Noah DL; Williams TB; Rowe T; Treanor JJ
J Infect Dis; 2008 Sep; 198(5):635-41. PubMed ID: 18694338
[TBL] [Abstract][Full Text] [Related]
10. Antibody response to influenza vaccine in coronary artery disease: a substudy of the FLUCAD study.
Brydak LB; Romanowska M; Nowak I; Ciszewski A; Bilińska ZT
Med Sci Monit; 2009 Jul; 15(7):PH85-91. PubMed ID: 19564837
[TBL] [Abstract][Full Text] [Related]
11. Effect of a second, booster, influenza vaccination on antibody responses in quiescent systemic lupus erythematosus: an open, prospective, controlled study.
Holvast A; van Assen S; de Haan A; Huckriede A; Benne CA; Westra J; Palache A; Wilschut J; Kallenberg CG; Bijl M
Rheumatology (Oxford); 2009 Oct; 48(10):1294-9. PubMed ID: 19692457
[TBL] [Abstract][Full Text] [Related]
12. [Homologous and heterologous antibody response induced in man by anti-influenza vaccine containing A/England/42/72 and b/Massachusetts/71].
Galanti B; Picciotto L; Ruggiero G; Romano E; Vaccaro L
Boll Ist Sieroter Milan; 1976 Mar; 55(71):13-7. PubMed ID: 1021152
[TBL] [Abstract][Full Text] [Related]
13. [Antibody response to trivalent anti-influenza vaccination (inactivated virus) A/Texas/1/77 H3N2), A/URSS/90/77 (H1N1), B/Hong Kong/8/73].
Mancini G; Andreoni M; Arangio-Ruiz G; Sarrecchia C; Donatelli I; Resta S; Rozera C; Sordillo P; Rocchi G
Boll Ist Sieroter Milan; 1982 May; 61(2):85-91. PubMed ID: 7126342
[TBL] [Abstract][Full Text] [Related]
14. A comparison of 2 influenza vaccine schedules in 6- to 23-month-old children.
Englund JA; Walter EB; Fairchok MP; Monto AS; Neuzil KM
Pediatrics; 2005 Apr; 115(4):1039-47. PubMed ID: 15805382
[TBL] [Abstract][Full Text] [Related]
15. Letter: Influenza virus subunit vaccine: a case for two doses.
Mackenzie JS
Med J Aust; 1976 Apr; 1(15):546-7. PubMed ID: 933947
[No Abstract] [Full Text] [Related]
16. Long-lasting immunogenicity of a virosomal vaccine in older children and young adults with type I diabetes mellitus.
Zuccotti GV; Scaramuzza A; Riboni S; Mameli C; Pariani E; Tanzi E; Zanetti A; Radaelli G
Vaccine; 2009 Aug; 27(39):5357-62. PubMed ID: 19607951
[TBL] [Abstract][Full Text] [Related]
17. Protective immunity against influenza H5N1 virus challenge in mice by intranasal co-administration of baculovirus surface-displayed HA and recombinant CTB as an adjuvant.
Prabakaran M; Velumani S; He F; Karuppannan AK; Geng GY; Yin LK; Kwang J
Virology; 2008 Oct; 380(2):412-20. PubMed ID: 18786689
[TBL] [Abstract][Full Text] [Related]
18. Oral influenza vaccination with live attenuated viruses. 1. Acceptability, immunogenicity and transmissibility.
Petrilli FL; Crovari P; Cuneo-Crovari P; Badolati G; Canepa R
Boll Ist Sieroter Milan; 1975 Oct; 54(4):312-22. PubMed ID: 1203087
[TBL] [Abstract][Full Text] [Related]
19. Antibody responses to influenza virus subunit vaccine in the aged.
Feery BJ; Evered MG; Morrison EI
Med J Aust; 1976 Apr; 1(15):540, 542. PubMed ID: 933946
[TBL] [Abstract][Full Text] [Related]
20. The humoral immune response and protective efficacy of vaccination with inactivated split and whole influenza virus vaccines in BALB/c mice.
Cox RJ; Hovden AO; Brokstad KA; Szyszko E; Madhun AS; Haaheim LR
Vaccine; 2006 Nov; 24(44-46):6585-7. PubMed ID: 16839650
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
